OGEN - ORAGENICS INC
0.8999
0.011 1.267%
Share volume: 208,673
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.89
0.01
0.01%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-13-2024 | 03-14-2025 | 05-09-2025 | 08-08-2025 | 11-07-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 2.437 M | 3.355 M | 2.026 M | 1.714 M | 3.124 M | |
| Selling general and admin | 1.558 M | 1.690 M | 1.685 M | 1.265 M | 2.193 M | |
| Research and development | 879.041 K | 1.665 M | 341.542 K | 449.679 K | 930.894 K | |
| Total expenses | 2.437 M | 3.355 M | 2.026 M | 1.714 M | 3.124 M | |
| 37.67% | -39.61% | -15.40% | 82.23% | |||
| Operating income | -2.437 M | -3.355 M | -2.026 M | -1.714 M | -3.124 M | |
| Ebit | -2.462 M | -3.349 M | -2.028 M | -1.717 M | -3.128 M | |
| Pretax income | -2.463 M | -3.349 M | -2.217 M | -2.272 M | -3.067 M | |
| 35.98% | -33.80% | 2.48% | 34.97% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.463 M | -3.349 M | -2.217 M | -2.272 M | -3.067 M | |
| -35.98% | 33.80% | -2.48% | -34.97% |